Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IART
#2285
Integra LifeSciences Holdings Corporation - Common Stock
16.8
9
USD
0.00%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.24%
Monthly Change
+2.43%
6 month change
+53.13%
Year Change
+4.78%
Previous Close
16.8
5
Open
16.8
9
Low
16.8
9
High
16.8
9
Volume
151
Markets
US Stock Market
Healthcare
Medical Devices
IART
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
84.37 M
83.24 M
81.64 M
78.22 M
77.22 M
77.94 M
77.77 M
Valuation ratios
Enterprise value
6.45 B
6.5 B
5.43 B
4.52 B
3.2 B
2.5 B
2.87 B
Price to earnings ratio
41.35
33.83
25.79
51.49
-252
-1.84
-167.89
Price to sales ratio
4.03
3.71
2.99
2.25
1.08
0.58
—
Price to cash flow ratio
27.14
18.33
17.59
24.83
13.5
18.9
15.18
Price to book ratio
3.65
3.4
2.58
2.19
1.13
0.91
0.31
Enterprise value to EBITDA ratio
16.79
14.77
11.42
12.59
10.1
-13.19
—
Profitability ratios
Return on assets %
0.04
0.04
0.05
0.02
-0
-0.14
0
Return on equity %
0.09
0.1
0.1
0.04
-0
-0.49
0
Return on invested capital %
11.64
20.43
25.46
11.42
1.24
-58.12
2.35
Gross margin %
62.03
61.24
62.29
57.39
54.77
50.86
52.47
Operating margin %
11.03
12.79
15.34
7.23
1.76
-30.17
4.61
EBITDA margin %
27.99
28.51
30.53
23.27
19.68
-11.6
20.16
Net margin %
9.76
10.96
11.59
4.39
-0.43
-31.58
1.07
Liquidity ratios
Quick ratio
2.31
2.46
2.61
2.18
0.71
1.46
2.11
Current ratio
3.09
3.39
3.62
3.45
1.17
2.54
3.6
Inventory turnover
1.66
1.91
1.83
1.84
1.78
1.63
0.4
Asset turnover
0.4
0.42
0.41
0.4
0.41
0.45
0.12
Solvency ratios
Debt to assets ratio
0.4
0.38
0.34
0.37
0.42
0.49
0.5
Debt to equity ratio
0.95
0.85
0.74
0.89
1.1
1.69
1.71
Long term debt to total assets ratio
0.24
0.22
0.2
0.2
0.19
0.2
0.2
Long term debt to total equity ratio
0.58
0.5
0.43
0.49
0.49
0.7
0.68
Per share metrics
Operating cash flow per share
2.39
3.65
3.17
1.74
1.68
0.66
1.11
EBIT per share
1.78
2.31
2.86
1.39
0.37
-6.43
0.85
EBITDA per share
4.51
5.14
5.69
4.47
4.12
-2.47
4.24
Total debt per share
16.92
16.77
16.03
17.56
22.01
23.06
22.77
Cash per share
5.52
6.01
5.47
3.85
3.55
3.44
3.51
Net current asset value per share
14.52
13.5
13.91
13.17
14.05
15.12
15.24
Tangible book value per share
17.77
19.71
21.61
19.77
20.07
13.61
13.35
Working capital per share
9.81
9.52
10.07
9.35
2.07
9.18
11.01
Book value per share
17.77
19.71
21.61
19.77
20.07
13.61
13.35
News
Integra (IART) Down 1.6% Since Last Earnings Report: Can It Rebound?
Why Integra LifeSciences (IART) is a Top Value Stock for the Long-Term
Can IART's SurgiMend Relaunch Help Drive a Broader 2027 Recovery?
Is IART Still Attractive as Its Low Valuation Meets Execution Risks?
Here's Why Integra LifeSciences (IART) is a Strong Momentum Stock
Zacks.com featured highlights include Bassett Furniture, Aveanna Healthcare and Integra LifeSciences
Integra LifeSciences Holdings Corporation (IART) Q2 2026 Earnings Call Transcript
3 Stocks Showing Breakout Potential Ahead of August
Integra (IART) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Integra LifeSciences (IART) Q2 Earnings Top Estimates
Here's Why Integra LifeSciences (IART) is a Strong Value Stock
Reasons to Retain Align Technology Stock in Your Portfolio for Now